LeMaitre Vascular, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5255582018
USD
85.70
2.02 (2.41%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
219.86
193.48
161.65
154.42
129.37
117.23
105.57
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
219.86
193.48
161.65
154.42
129.37
117.23
105.57
Raw Material Cost
74.75
72.53
62.94
59.24
49.79
39.82
33.39
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.20
0.00
0.00
2.22
1.31
0.00
0.00
Selling and Distribution Expenses
77.08
66.91
55.64
46.96
41.16
46.96
43.25
Other Expenses
1.54
1.70
1.33
0.96
0.88
0.93
0.82
Total Expenditure (Excl Depreciation)
167.47
156.40
131.87
118.00
101.05
96.05
84.83
Operating Profit (PBDIT) excl Other Income
52.400000000000006
37.1
29.8
36.4
28.3
21.200000000000003
20.7
Other Income
4.82
2.76
0.66
0.08
0.35
0.50
7.71
Operating Profit (PBDIT)
66.82
49.36
39.88
45.98
36.89
27.09
32.77
Interest
0.20
0.00
0.00
2.22
1.31
0.00
0.00
Exceptional Items
-0.13
-0.37
-2.95
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
145.12
120.96
98.71
95.19
79.58
77.42
72.18
Depreciation
9.61
9.52
9.43
9.47
8.22
5.42
4.32
Profit Before Tax
56.88
39.48
27.49
34.29
27.36
21.68
28.44
Tax
12.84
9.37
6.85
7.38
6.14
3.75
5.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
44.04
30.11
20.64
26.91
21.22
17.93
22.94
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
44.04
30.11
20.64
26.91
21.22
17.93
22.94
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
44.04
30.11
20.64
26.91
21.22
17.93
22.94
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
337.29
297.90
268.20
254.15
172.57
148.14
130.24
Earnings per share (EPS)
1.93
1.34
0.93
1.25
1.04
0.88
1.13
Diluted Earnings per share
1.93
1.34
0.93
1.25
1.04
0.88
1.13
Operating Profit Margin (Excl OI)
23.83%
19.17%
18.42%
23.59%
21.89%
18.07%
19.64%
Gross Profit Margin
30.24%
25.32%
22.84%
28.34%
27.5%
23.11%
31.04%
PAT Margin
20.03%
15.56%
12.77%
17.42%
16.4%
15.3%
21.73%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 13.64% vs 19.67% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 46.18% vs 46.12% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 33.05% vs 18.88% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of LeMaitre Vascular, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
219.86
837.60
-617.74
-73.75%
Other Operating Income
0.00
0.00
0.00
Total Operating income
219.86
837.60
-617.74
-73.75%
Raw Material Cost
74.75
252.20
-177.45
-70.36%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.20
2.80
-2.60
-92.86%
Selling and Distribution Expenses
77.08
559.60
-482.52
-86.23%
Other Expenses
1.54
11.06
-9.52
-86.08%
Total Expenditure (Excl Depreciation)
167.47
925.20
-757.73
-81.90%
Operating Profit (PBDIT) excl Other Income
52.39
-87.60
139.99
159.81%
Other Income
4.82
-11.80
16.62
140.85%
Operating Profit (PBDIT)
66.82
-37.80
104.62
276.77%
Interest
0.20
2.80
-2.60
-92.86%
Exceptional Items
-0.13
-21.30
21.17
99.39%
Gross Profit (PBDT)
145.12
585.40
-440.28
-75.21%
Depreciation
9.61
61.60
-51.99
-84.40%
Profit Before Tax
56.88
-123.50
180.38
146.06%
Tax
12.84
3.80
9.04
237.89%
Provisions and contingencies
0
0
0.00
Profit After Tax
44.04
-127.30
171.34
134.60%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
44.04
-127.30
171.34
134.60%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
44.04
-127.30
171.34
134.60%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
337.29
701.10
-363.81
-51.89%
Earnings per share (EPS)
1.93
-1.41
3.34
236.88%
Diluted Earnings per share
1.93
-1.41
3.34
236.88%
Operating Profit Margin (Excl OI)
23.83%
-10.46%
0.00
34.29%
Gross Profit Margin
30.24%
-7.39%
0.00
37.63%
PAT Margin
20.03%
-15.20%
0.00
35.23%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 21.99 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 13.64% vs 19.67% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 4.40 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 46.18% vs 46.12% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.20 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 33.05% vs 18.88% in Dec 2023

Annual - Interest
Interest 0.02 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.83%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023